Kanecia Obie Zimmerman

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Kanecia Obie Zimmerman sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials none currently recruiting 6 completed early-phase tilt upper quartile by trial count

Kanecia Obie Zimmerman: 7 sponsored US clinical trials, none currently recruiting.

Kanecia Obie Zimmerman sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. 0 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Long Coronavirus Disease 2019 (Covid19), with 1 trials.

Upper-quartile sponsor footprint

Kanecia Obie Zimmerman sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

How the Kanecia Obie Zimmerman early-phase archive is shaped

7 indexed studies, none listed as recruiting (0% open); 6 completed (86%).

Phase mix: 0 late (III/IV) vs 7 early (I/II) (early-phase heavy).

Top condition: Long Coronavirus Disease 2019 (Covid19) (1 trial), 2 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Kanecia Obie Zimmerman: archived-pipeline peers nationwide

Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Kanecia Obie Zimmerman sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-07-11 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Kanecia Obie Zimmerman3M4Life Research89bioAbbott Diagnostics Division10xBio22nd Century Group23andMe3-C Institute for Social Development
Kanecia Obie Zimmerman sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-07-11 snapshot).

Kanecia Obie Zimmerman sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Kanecia Obie Zimmerman page

7 registered trials is a research-attention snapshot, not an endorsement of Kanecia Obie Zimmerman or any single study.

  • None of Kanecia Obie Zimmerman's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Long Coronavirus Disease 2019 (Covid19) is the condition Kanecia Obie Zimmerman studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Long Coronavirus Disease 2019 (Covid19) trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Kanecia Obie Zimmerman pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.